Oversold

NEPH

Valuation62/ 100
Cash flow & growth64/ 100
Upside potential69/ 100
Risk potential22/ 100

NEPH's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to improving growth and profitability, though analyst coverage is limited.

Score change since last week

The score rose 2 points, mainly due to valuation and price changes. Price fell 10.8%, from $4.55 to $4.06. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 2.5 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 25.6× versus the full-history median of 36× shown in the valuation table, producing 60.5/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 61.6/100. The model applies a 17.1% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 35.9× (18-month half-life). The favorable scenario uses 30.6× PE and $0.2 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +24.2%, earnings +27.1%, operating margin -0.1 percentage points. Free cash flow is -3.2% of revenue. The business score is 64.1/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $0.20 of EPS and a 30.6× PE, suggesting a share price of about $6.16. Valuation history and outlook inform the PE.

The displayed favorable scenario is 51.6% upside, or about $6.15.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.14 of EPS and a 23.6× PE, suggesting a share price of about $3.19 — 22% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

NEPH vs Historical averages

MetricCurrentAverageRelative
PE26x60x57% lower
PE percentile45192% lower
EPS$0.16-$0.28$0.44 higher
FCF-$661K-$1.4M+$768.6K
Loading historical comparisons…

NEPH’s earnings are above their historical averages, while its earnings multiple is lower.

NEPH Forward outlook

MetricOutlook
Forward valuationStrongly improving
Forward earningsStrong growth
Forward revenueGrowth
Forward profitabilityExpanding
Analyst coverageLimited
Estimate dispersionTight

NEPH’s outlook is generally improving, though analyst coverage is limited.

NEPH PE Valuation

Loading pe valuation table…

This table applies NEPH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

NEPH Earnings Per Share

Loading earnings per share…

This chart tracks NEPH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

NEPH Quarterly Revenue

Loading quarterly revenue…

This chart tracks NEPH's quarterly revenue over time and shows how sales are changing from year to year.

NEPH Free Cash Flow

Loading free cash flow…

This chart tracks NEPH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

NEPH Total Shares

Loading shares over time…

This chart tracks changes in NEPH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

NEPH Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

NEPH PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares NEPH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

NEPH Weekly Price

Loading weekly price…

This chart uses NEPH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

NEPH Weekly Moving Averages

Loading weekly moving averages…

This chart compares NEPH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

NEPH Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.